Position in GSK
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$375,484
-$237,676 QoQ
Shares Held
7,163
-35.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#539
of 1,033 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GSK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CAUSEWAY CAPITAL MANAGEMENT LLC holds $2,118,676,056 across 8 Drug Manufacturers - General names. GSK ranks #7 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
9,357,390 | $1,774,348,291 | |
| 2 | MRK |
Merck & Co., Inc.
|
954,932 | $122,708,762 | |
| 3 | NVO |
Novo Nordisk A S
|
1,677,615 | $80,424,863 | |
| 4 | BIIB |
Biogen Inc.
|
278,283 | $60,125,824 | |
| 5 | PFE |
Pfizer Inc
|
1,916,801 | $46,156,568 | |
| 6 | SNY |
Sanofi
|
804,056 | $34,301,028 | |
| 7 | GSK |
GSK plc
This page
|
7,163 | $375,484 | |
| 8 | NVS |
Novartis AG
|
1,501 | $235,236 |
All Filings in GSK
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $375,484 | 7,163 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $613,160 | 11,110 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $1,662,308 | 33,897 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $50,799,363 | 1,177,001 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $42,511,718 | 1,107,076 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $42,920,937 | 1,107,923 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $36,409,935 | 1,076,580 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $36,685,957 | 897,406 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $29,011,097 | 753,535 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $31,603,120 | 737,185 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $29,479,043 | 795,441 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $20,472,078 | 564,747 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $14,235,685 | 399,430 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $11,355,712 | 319,160 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $8,329,339 | 237,033 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $5,401,699 | 183,544 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $11,022,068 | 258,163 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $11,038,850 | 258,378 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $7,722,700 | 178,546 | Shares | Sole | 2022-02-11 | |
| No filing history on record for this holder in this stock. | ||||||